Floxuridine
Resected Liver Metastases From Colorectal Cancer
Ye XuSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Resected Liver Metastases From Colorectal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE Ye Xu | Phase 2/3 | B |
HEPARIN Ye Xu | Phase 2/3 | B |
Same molecule, other indications
Floxuridine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →